Integrin α6β4 is upregulated in pancreatic carcinoma, where signaling promotes metastatic properties, in part by altering the transcriptome. Such alterations can be accomplished through DNA demethylation of specific promoters, as seen with the pro-metastatic gene S100A4. I found that signaling from integrin α6β4 dramatically upregulates expression of amphiregulin (AREG) and epiregulin (EREG), ligands for the epidermal growth factor receptor (EGFR), and that these ligands promote pancreatic carcinoma invasion. To determine if AREG and EREG are regulated by DNA methylation, pancreatic cancer cells with low AREG and EREG expression were treated with the DNA methyltransferase inhibitor 5-aza-2’-deoxycytidine (5-Aza-CdR), resulting in stable overexpression of AREG and EREG, and this induction required signaling from integrin α6β4. Similarly, treatment of cells with high integrin α6β4 with the methyl donor S-adenosylmethionine inhibited gene expression of AREG and EREG. Whole genome bisulfite sequencing on pancreatic cancer cells reveled hypomethylation of the promoter regions of AREG and EREG when integrin α6β4 is high, and these regions correspond to H3K27Ac, indicative of enhancer location. Interestingly, I also observed genome-wide DNA demethylation, and a large proportion of altered CpGs correspond to potential enhancers. It is currently accepted that active DNA demethylation occurs via DNA repair. I tested this hypothesis by treating cells with Gemcitabine, which inhibits multiple components of DNA repair, including DNA demethylation mediated by GADD45A. Gemcitabine treatment resulted in marked reduction in AREG and EREG expression. To further test the involvement of GADD45A, I used RNAi-mediated knockdown or cDNA overexpression to alter GADD45A levels. In both instances, AREG and EREG expression positively correlated with GADD45A, particularly when integrin α6β4 is high, indicating that GADD45A is a rate-limiting step in AREG and EREG overexpression. Similarly, using stable shRNA, I show that Thymine DNA Glycosylase (TDG), and TET1 known modulators of DNA demethylation, are required for AREG and EREG expression in integrin α6β4 high cells, and nuclear localization of TDG is much higher in cells with high integrin α6β4. Using a specific inhibitor I found that AREG and EREG expression is dependent on Parp-1. Finally, I determined that integrin α6β4 signaling enhances cells ability to respond to and survive in the presence of DNA damage, and that active DNA repair is required for integrin α6β4 mediated DNA demethylation. Taken together, these data indicate that DNA repair is required to maintain overexpression of AREG and EREG in response to signaling from integrin α6β4 and that integrin α6β4 promotes this overexpression by enhancing DNA repair.

The stability of DNA is a critical factor for several diseases, the most prevalent of which is cancer. Several neurodegenerative and accelerated aging diseases are also characterized by genomic instability. The number and complexity of DNA repair pathways that human cells possess underscores the importance of genomic stability. These pathways ensure that damaged DNA is repaired and that a cells complement of DNA remains stable upon cell division. How one particular type of DNA alteration, a DNA loop, is processed in human cells was the focus of this study. We have employed an in vitro system to study defined DNA loop substrates by human nuclear extracts. The influence of either a 5 or 3 nick, the range of loop sizes processed, and the role of DNA mismatch repair, DNA nucleotide excision repair, and the Werner Syndrome helicase proteins were variables tested. The results indicate tha t DNA loops containing between 5 to 12 nucleotides are processed in a strand - specific manner when either a 5 or 3 nick is present , with repair being targeted solely to the nicked strand . This repair occurs by both mismatch repair dependent and independent pathways. The processing of DNA loops containing 30 nucleotides in length is directed either by a 5 nick, or by the loop itself, but not by a 3 nick. The nick independent pathway results solely in loop removal. The large loop pathway is independent of mismatch repair, nucleotide excision repair, and the WRN helicase/exonuclease protein. Both of the 5 nick directed pathways occur by excision that initiates at the pre- existing nick and proceeds towards the loop along the shortest path between the nick and loop. DNA resynthesis occurs using either DNA polymerase , , or and also initiates at the pre-existing 5 nick. The 3 nick directed intermediate loop repair pathway proceeds in a similar fashion, likely after a nick is made 5 to the loop region on the strand that contained the pre-existing nick. DNA synthesis inhibition has only a minor affect on the nick independent loop removal pathway as only a short tract of DNA surrounding the loop site is processed. In total, the results point to at least 3 novel pathways that process DNA loops that likely contribute to total genomic stability.

Group I intron-derived ribozymes are catalytic RNAs that have been engineered to catalyze a variety of different reactions, in addition to the native self-splicing reaction. One such ribozyme, derived from a group I intron of Pneumocystis carinii, can modify RNA transcripts through either the excision or insertion of RNA sequences. These reactions are mediated through the trans excision-splicing (TES) or trans insertionsplicing (TIS) reaction pathways. To increase our current understanding of these reactions, as well as their general applicability, a mechanistic and kinetic framework for the TES reaction was established. Furthermore, additional ribozymes were investigated for their ability to catalyze the TES reaction. Lastly, the development of the TIS reaction into a viable strategy for the manipulation of RNA transcripts was investigated. The TES reaction proceeds through two reaction steps: substrate cleavage followed by exon ligation. Mechanistic studies revealed that substrate cleavage is catalyzed by the 3’ terminal guanosine of the Pneumocystis ribozyme. Moreover, kinetic studies suggest that a conformational change exists between the individual reaction steps. Intron-derived ribozymes from Tetrahymena thermophila and Candida albicans were also investigated for their propensity to catalyze the TES reaction. The results showed that each ribozyme could catalyze the TES reaction; however, Pneumocystis carinii is the most effective using the model constructs. Investigations of the TIS reaction focused on developing a new strategy for the insertion of modified oligonucleotides into an RNA substrate. These studies used oligonucleotides with modifications to the sugar, base, and backbone positions. Each of the modified oligonucleotides was shown to be an effective TIS substrate. These results demonstrate that TIS is a viable strategy for the incorporation of modified oligonucleotides, of varying composition, into an intended RNA target. The results from these studies show that group I introns are highly adaptable for catalyzing non-native reactions, including the TES and TIS reactions. Furthermore, group I introns are capable of catalyzing these unique reactions through distinct reaction pathways. Overall, these results demonstrate that group I introns are multi-faceted catalysts.

Nucleotide excision repair (NER) is one of the major repair systems for removal of DNA lesions. The NER pathway has evolved mainly to repair UV-induced DNA damage and is also active against a broad range of endogenously generated oxidative lesions. Defects in NER result in the human inherited disorder xeroderma pigmentosum (XP), which is characterised by UV hypersensitivity and a 1000-fold increased risk of skin cancer. ERCC1 is essential for the NER pathway where it acts in a complex with the XPF protein to make the incision 5' to the DNA lesion. The normal 1.1kb Ercc1 transcript is expressed in all tissues. Our group has discovered a second larger 1.5 kb transcript, which initiates from an alternative promoter, and is the most abundant Ercc1 transcript in mouse skin. The aims of this project were: 1, To investigate the role of ERCC1 and of the 1.5kb skin specific Ercc1 transcript in protecting the skin against UV-induced DNA damage. 2, To study the importance of ERCC1 in melanoma skin cancer and investigate ERCC1as a possible target for therapy against melanoma. Using a panel of Ercc1 wild-type and deficient cells, we established a quantitative western blotting system to study the expression of ERCC1 in a range of mouse tissues and mouse and human cell types. Although the skin-specific Ercc1 transcript was found to be present at much higher levels in the skin of albino compared to pigmented mouse strains, this did not result in an elevated level of ERCC1 protein. We were also unable to demonstrate that UV-irradiation, or other stress-inducing treatments resulted in increased levels of ERCC1 protein in cultured mouse keratinocytes. We investigated the DNA methylation status of the normal Ercc1 promoter and that of two potential upstream promoter regions that were candidates for the source of the 1.5kb skin-specific Ercc1 transcript. We found no evidence that they were the source and, instead, used 5' RACE analysis to locate the skin-specific promoter to a polymorphic region 500bp upstream of the normal initiation site. In albino strains this region contains a SINE element, which we hypothesize could be involved in the production of the skin-specific Ercc1 transcript. We also investigated the protein level of ERCC1 and other DNA repair proteins, including XPF, MSH2, MSH6 and MLH1 in human melanoma cells and ovarian tumour cells. Significantly elevated protein levels of ERCC1 and XPF, as well as the mismatch repair protein MLH1 were found in melanoma cells. This could possibly contribute to the higher resistance to chemotherapy in melanoma, although the melanoma cell lines we tested did not show increased resistance to UV and cisplatin compared to the ovarian cancer cells tested. When Ercc1 proficient mouse melanoma cells were xenografted into nude mice the xenografts grew rapidly. Cisplatin treatment caused an initial shrinkage of the tumours, but re-growth rapidly followed. Cells re-isolated into culture from cisplatin treated xenografts had significantly higher levels of ERCC1 protein than either input cells, or cells re-isolated from untreated xenografts. An isogenic Ercc1 deficient derivative of the Ercc1 proficient mouse melanoma cell line grew as rapidly as the parent line in vitro, but grew much more slowly as xenografts. In addition, the xenografts shrank completely following cisplatin treatment and did not recover. This suggests that ERCC1 could be a drug target for melanoma therapy.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

KplE1 est l’un des dix prophages présents sur le chromosome de la souche Escherichia coli K12. Nous avons montré in vivo que ce prophage est compétant pour s’exciser du chromosome bactérien bien qu’il soit incapable de former des particules virales et de lyser son hôte. Au laboratoire, nous avons identifié les protéines IntS (intégrase) et TorI (RDF), codées sur le prophage KplE1, et la protéine IHF (NBP) de l’hôte comme seules impliquées dans le mécanisme de recombinaison spécifique de site (RSS). Nous avons cartographié sur les régions attL et attR, les sites de fixations des protéines de recombinaison permettant l’assemblage de l’intasome, le complexe nucléoprotéique compétant pour la RSS. L’ensemble de ces sites ainsi que les gènes intS et torI qui chevauchent respectivement les régions attL et attR, ont permis de définir un module de recombinaison de type KplE1. Ce module est très conservé et se retrouve chez des phages infectant différentes souches d’E. coli et de shigella. Le modèle en terme de RSS est celui décrit pour les bactériophages de type λ. Cependant, le nombre et l’organisation des sites de recombinaison suggèrent que l’architecture de l’intasome de type KplE1 diffère de celle de λ. Nos résultats renforcent ainsi l’idée que l’assemblage de l’intasome est spécifique du module de RSS considéré même si, in fine, la réaction catalysée demeure similaire.En ce qui concerne l’expression des gènes intS et torI, le fait que ces gènes soient localisés à chacune des extrémités du prophage, rend ainsi impossible leur couplage transcriptionnel à partir d’un promoteur commun au moment de la commutation lyse/lysogénie, tel qu’il est connu pour les phages lambdoïdes. De part son orientation atypique sur attL, la présence de sites de fixations des protéines IntS et TorI au niveau du promoteur du gène intS, nous ont logiquement amené à étudier sa régulation. Nous avons ainsi montré que le gène intS est négativement régulé par son propre produit ainsi que par la protéine RDF TorI. Nos résultats in vivo et in vitro indiquent que l’efficacité de la réaction de recombinaison excisive est intimement liée à la quantité d’intégrase présente, pouvant alors justifier la raison d’être de ce contrôle strict de l’expression du gène intS. En parallèle, une approche in silico a révélé que cette orientation atypique du gène codant pour l’intégrase est largement répandue sur les génomes des prophages, nous amenant à généraliser ce mécanisme atypique de régulation négative de l’intégrase. / KplE1 is one of the 10 prophage region present on the Escherichia coli K12 chromosome. We showed in vivo that this prophage is fully competent to excise from the bacterial chromosome, although it is unable to form viral particles and lyse its host. In the laboratory, we have identified Ints (integrase) and TorI (RDF) proteins, encoded on the KplE1 prophage, and the host protein IHF (NBP) only involved in the mechanism of site-specific recombination (SSR). We have mapped on attL and attR regions, the binding sites of recombinant proteins for the assembly of the intasome, the nucleoprotein complex competent for SSR. All of these sites as well as intS and torI genes that overlap respectively attL and attR regions, have permit to define a KplE1 recombination module. This module is highly conserved and is found among phages infecting different E. coli and shigella strains. The model in terms of RSS is that described for λ bacteriophage. However, the number and organization of recombination sites suggests that the architecture of the KplE1 intasome differs from that of λ. Our findings reinforce the idea that the intasome assembly is specific to the SSR module considered even if ultimately the catalyzed reaction is similar.Regarding the intS and torI gene expressions, the fact that these genes are located at each end of the prophage, prevented the transcriptional coupling of these genes from a common promoter when the lysis/lysogeny switch occurs. Because of its atypical orientation on attL, and the presence of IntS and TorI protein binding sites that overlap its promoter region, we have logically studied the regulation of the intS gene. We have shown that intS is negatively regulated by both IntS and TorI proteins. Our in vivo and in vitro results suggest that the efficiency of the excision recombination reaction is closely related to the amount of this integrase, which can justify the strict control of the intS gene expression. In parallel, an in silico approach has revealed that the atypical orientation of the integrase gene is widespread in prophage genomes, leading us to generalize this atypical mechanism of negative regulation of integrase

The G-quadruplex DNA is a four-stranded DNA structure that is highly susceptible to oxidation due to its G-rich sequence and its structure. Oxidative DNA base damages can be mutagenic or lethal to cells if they are left unrepaired. The base excision repair (BER) pathway is the predominant pathway for repair of oxidized DNA bases. DNA glycosylases are the first enzymes in BER and are responsible for removing base lesions from DNA. How DNA glycosylases remove base lesions from duplex and single-stranded DNA has been intensively studied, while how they act on G-quadruplex DNA remains to be explored. In Chapter II of this dissertation, we studied the glycosylase activity of the five mammalian DNA glycosylases (OGG1, NTH1, NEIL1, NEIL2 and mouse Neil3) on G-quadruplex DNA formed by telomere sequences that contain a single base lesion. We found that telomeric sequences that contain thymine glycol (Tg), 8-oxo-7,8-dihydroguanine (8-oxoG), guanidinohydantoin (Gh) or spiroiminodihydantoin (Sp) all formed the basket form of an antiparallel G-quadruplex DNA structure in Na+ solution. We also showed that no glycosylase was able to remove 8-oxoG from quadruplex DNA, while its further oxidation products, Sp and Gh, were good substrates for mNeil3 and NEIL1 in quadruplex DNA. In addition, mNeil3 is the only enzyme that removes Tg from quadruplex DNA and the glycosylase strongly prefers Tg in the telomere sequence context in both single-stranded and double-stranded DNA. In Chapter III, we extended our study to telomeric G-quadruplex DNA in K+ solution and we also studied quadruplex DNA formed by promoter sequences. We found that 8-oxoG, Gh and Sp reduce the thermostability and alter the folding of telomeric quadruplex DNA in a location-dependent manner. Also, the NEIL1 and NEIL3 DNA glycosylases are able to remove hydantoin lesions but none of the glycosylases, including OGG1, are able to remove 8-oxoG from telomeric quadruplex DNA in K+ solution. Interestingly, NEIL1 or NEIL3 do not efficiently remove hydantoin lesions at the site that is most prone to oxidation in quadruplex DNA. However, hydantoin lesions at the same site in quadruplex DNA are removed much more rapidly by NEIL1, NEIL2 and NEIL3, when an extra telomere TTAGGG repeat is added to the commonly studied four-repeat quadruplex DNA to make it a five-repeat telomere quadruplex DNA. We also show that APE1 cleaves furan in selected positions in Na+-coordinated telomeric quadruplex DNA structures. We use promoter sequences of the VEGF and c-MYC genes as models to study promoter G-quadruplex DNA structures, and show that the NEIL glycosylases primarily remove Gh from Na+-coordinated antiparallel quadruplex DNA but not from K+-coordinated parallel quadruplex DNA containing VEGF or c-MYC promoter sequences. Taken together, our data show that the NEIL DNA glycosylases may be involved in both telomere maintenance and gene regulation.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

INTRODUÇÃO: O câncer gástrico precoce que invade a submucosa pode apresentar acometimento linfonodal em torno de 20% dos casos. O tratamento cirúrgico clássico com gastrectomia e linfadenectomia D2 é um procedimento não isento de mortalidade e morbidade. Determinar quais pacientes têm maior risco de acometimento linfonodal permitiria tratamentos com menores complicações. Recentemente diversos autores relatam maior expressão imuno-histoquímica de p53 e p21ras em tumores avançados e com pior prognóstico. Tem sido relatada também perda da expressão de p21waf1, p27kip1 e p16ink4a nos tumores avançados e algumas publicações relatam também relação entre a expressão dos marcadores e acometimento linfonodal. MÉTODOS: Foram estudados retrospectivamente 81 pacientes submetidos à gastrectomia com linfadenectomia D2 no período de 1971 a 2004 no Serviço de Cirurgia do Estômago e Intestino Delgado do Departamento de Gastroenterologia do HC-FM/USP. Os blocos de parafina contendo fragmentos dos tumores foram recuperados e novo exame histopatológico confirmou o diagnóstico. Selecionaram-se áreas representativas de mucosa normal, mucosa metaplásica e tumor para confecção de novos blocos de tissue microarrays. Foi avaliada a expressão imuno-histoquímica de p21ras, p53, p21waf1/cip1, p27kip1 e p16ink4a nos tecidos. Foram investigadas as correlações entre a expressão dos marcadores e as características clínico-patológicas dos pacientes. A análise da associação entre os dados clínicos e a positividade dos marcadores foi realizada pelo teste Qui-quadrado. RESULTADOS: Na mucosa normal, metaplásica e tumoral p53 apresentou positividade em 53%, 87,3% e 87,1% dos casos respectivamente. Nos mesmos tecidos p21ras apresentou positividade de 85,3%, 86% e 96,8%. Para p16ink4a a positividade foi de 46,3%, 91,1% e 86%. Para p27kip1 a positividade foi de 60%, 94,7% e 95,3%. Para p21waf1/cip1 a positividade foi 32,4%, 72,7% e 71,4%. Todos os tumores tiveram alguma positividade para p53. Os tumores com acometimento linfonodal apresentaram hiper-expressão(+4) de p53 em 47% dos casos contra 17% nos pacientes que não tinham acometimento. Nenhum tumor com positividade para p53 baixa(0 e +1) teve linfonodos acometidos. Nenhum tumor com p21ras negativo apresentou linfonodos acometidos. Nos pacientes com acometimento linfonodal p21ras teve positividade intensa(+2 e +3) em 88% dos casos contra 50% dos casos sem acometimento linfonodal. Houve positividade intensa(+2,+3 e +4) de p21waf1/cip1 em 71% dos tumores com acometimento linfonodal contra 28% nos pacientes sem acometimento. Não observamos perda de expressão de p21waf1, p27kip1 e p16ink4a nos tumores com acometimento linfonodal. Na mucosa normal p16ink4a foi hiper-expresso (+4) em 20% dos casos com infiltração perineural contra 0% nos casos sem acometimento. O mesmo marcador foi hiperexpresso em 50% dos casos com infiltração vascular contra 0% dos casos sem infiltração. Os tumores com padrão de infiltração Sm2 tiveram pouca positividade(0 e +1) de p27kip1 na mucosa normal em 89% dos casos contra 55% dos casos Sm1. CONCLUSÕES: Maior expressão de p53, p21ras e p21waf1/cip1 no tumor teve relação estatística significante com acometimento linfonodal. Ocorre aumento da expressão imuno-histoquímica de todos os marcadores da mucosa normal para o tumor. A maior hiper-expressão de p16ink4a na mucosa normal de pacientes tem relação com infiltração perineural e vascular nos tumores. A expressão dos marcadores é diferente nas raças estudadas. As pacientes do sexo feminino apresentam maior positividade de p21waf1 na mucosa normal. Pacientes com história familiar de câncer gástrico apresentam maior positividade de p16ink4a na mucosa normal, menor positividade de p21waf1/cip1 e p21ras na mucosa metaplásica. Maior positividade na mucosa normal de p21waf1/cip1 relaciona-se a sexo feminino e infiltração tipo Sm1 / INTRODUCTION: Early gastric cancer that invades the submucosa might have a lymphonodal involvement in about 20% of the cases. Gastrectomy and D2 linfadenectomy is a procedure that has presented mortality and morbidity. Determining which patients would have a greater risk of lymphonodal involvement would allow treatments with fewer complications. Recently, several authors reported a greater immunohistochemical expression of p53 and p21ras in advanced tumors with worst prognosis. It has also been reported the expression loss of p21wafl, p27kip1, and p16ink4a in advanced tumors, and, some studies also observed the relationship between the markers expression and lymphonodal involvement. METHODS: Eightyone patients who had undergone gastrectomy with D2 linfadenectomy from 1971 to 2004 were retrospectively studied. A new histopathological exam confirmed the diagnosis. Representative areas of both normal and metaplastic mucosa and of the tumor were selected for obtaining new blocks of tissue microarrays. The immunohistochemical expression of p21ras, p53, p21waf1/cip1, p27kip1 and p16ink4a in the tissues was evaluated. RESULTS: In normal, metaplastic and tumoral mucosa, p53 showed positivity in 53%, 87.3%, and 87.1% of the cases, respectively. In the same tissues, p21ras showed positivity in 85.3%, 86%, and 96.8%, respectively. The positivity of p16ink4a was 46.3%, 91.1%, and 86%, respectively. p27kip1 showed a positivity of 60%, 94.7%, and 95.3%, respectively. p21wafl/cip1 presented a positivity of 32.4%, 72.7%, and 71.4%, respectively. All tumors showed positivity for p53. Tumors with lymphonodal involvement presented hyperexpression (+4) of p53 in 47% of the cases versus 17% in patients who had not showed any involvement. No tumor with low positivity (0 and +1) of p53 showed lymphonodal involvement. No tumor with negative p21ras showed lymphonodal involvement. In patients with lymphonodal involvement, p21ras presented strong positivity (+2 and +3) in 88% of the cases versus 50% of the cases without lymphonodal involvement. There was a strong positivity (+2,+3, and +4) of p21wafl/cip1 in 71% of the tumors with lymphonodal involvement versus 28% in patients without involvement. It was not observed an expression loss of p21waf1, p27kip1 e p16ink4a in tumors with lymphonodal involvement. In normal mucosa, p16ink4a showed a hyper-expression (+4) in 20% of the cases with perineural invasion versus 0% of the cases without invasion. This same marker showed a hyper-expression in 50% of the cases with vascular invasion versus 0% of the cases without invasion. Tumors with Sm2 invasion pattern showed low positivity (0 and +1) of p27kip1 in normal mucosa in 89% of the cases versus 55% of the cases of Sm1 tumors. CONCLUSIONS: Higher expression of p53, p21ras, and p21wafl/cip1 in tumor showed a significant statistical relationship with lymphonodal involvement. A higher hyper-expression of p16ink4a in patients normal mucosa was related to perineural and vascular invasion of tumors

A radiação ultravioleta (UV) pode ser absorvida por diferentes moléculas celulares, incluindo o DNA no qual provoca distorções estruturais. As lesões mais comuns induzidas pela radiação UV são o ciclobutano de pirimidina (CPD) e o fotoproduto (6-4)-pirimidina-pirimidona [(6-4)PPs]. Estas lesões podem ser reparadas pela fotorreativação, caracterizada por ter uma única proteína (fotoliase) que remove lesões empregando luz visível (320-500 nm) como fonte de energia. Foram identificados dois tipos de fotoliases que diferem por sua especificidade ao substrato: CPD-fotoliase e (6-4)-fotoliase. Um outro mecanismo de reparo é o reparo por excisão de nucleotídeos (NER), um mecanismo que envolve múltiplos passos e proteínas. Enquanto os efeitos genotóxicos da UVC e UVB já estão relativamente esclarecidos e bem aceitos, ainda existem controvérsias sobre a genotoxicidade da radiação UVA, devido ao fato de ser fracamente absorvida pelo DNA. Alguns autores acreditam que os seus principais efeitos são gerados de forma indireta pela produção de espécies reativas de oxigênio enquanto outros acreditam que a UVA pode gerar danos ao DNA de forma direta, provocando a formação de dímeros de pirimidina. O objetivo deste trabalho foi verificar os efeitos genotóxicos da radiação UVA em fibroblastos humanos deficientes e proficientes em NER utilizando adenovírus recombinantes contendo uma ou outra fotoliase para verificar se as lesões CPD e (6-4)PP são geradas pela UVA e se elas teriam alguma importância nas respostas verificadas após irradiação. Foi verificado que as células deficientes no gene XPA são mais sensíveis à radiação UVA quando comparadas às células selvagens. Por meio da detecção imunológica, confirmamos a geração das lesões CPD, (6-4)PP e Dewar, fotoisômero da lesão (6-4)PP, após irradiação com UVA no genoma de células humanas. Empregando vetores adenovirais para transdução de fotoliase específica para lesões tipo CPD ou (6-4)PP, confirmamos que de fato essas lesões são formadas em células humanas deficientes em reparo de DNA após irradiação com UVA. Além disso, esses vírus permitiram verificar a relevância biológica dessas lesões na indução de morte celular em células XP-A irradiadas. De fato, os dados indicam que para doses baixas de radiação UVA essas lesões desempenham um importante papel na indução de morte. Não podemos descartar, porém, que lesões indiretas (provavelmente geradas por estresse oxidativo) também tenham papel na indução de morte pela radiação UVA, o que parece ser mais importante a doses médias e altas dessa radiação. / Ultraviolet radiation (UV) is absorbed by different cellular molecules, including DNA in which induces structural distortions. The most common lesions induced by UV radiation are the cyclobutane pyrimidine (CPD) and the photoproduct (6-4)-pyrimidine-pyrimidone [(6-4)PP]. These lesions can be repaired by the photoreactivation, characterized by a single protein (photolyase) that removes lesions using visible light (320-500 nm) as energy source. Two types of photolyases had been identified that differ by their substrate specificity: CPD-photolyase and (6-4)-photolyase. Another repair mechanism is the nucleotide excision repair (NER), a mechanism that involves multiple steps and proteins. While the genotoxic effects of UVB and UVC are already relatively well-understood and accepted, there is still controversy about the genotoxicity of UVA radiation, due to its low absorption by DNA. Some authors believe that the major effects are generated indirectly by the production of reactive oxygen species, while others believe that UVA can cause damage to DNA directly, inducing the formation of pyrimidine dimers. The aim of this study was to assess the genotoxic effects of UVA radiation in human fibroblasts deficient and proficient in NER, using recombinant adenovirus expressing the photolyases to verify if CPDs and (6-4)PPs are generated by UVA and whether they had any importance in the responses observed after irradiation. It was found that cells deficient in the XPA gene are more sensitive to UV radiation compared to wild type cells. By immunological detection, we confirm the generation of CPD, (6-4)PP and Dewar, photoisomer of the (6-4)PP lesion, in the genome of human cells after irradiation with UVA. Using adenoviral vectors for the transduction of photolyases specific for CPD or (6-4)PP lesions, we confirm that in fact these lesions are generated in human cells deficient in DNA repair after irradiation with UVA. Moreover, these viruses allowed us to verify the biological relevance of these lesions in the induction of cell death in irradiated XP-A cells. In fact, our data indicates that for low doses of UVA radiation, these lesions play important roles in the induction of death. We cannot rule out, however, that indirect lesions (probably caused by oxidative stress) could also have a role in the induction of death by UVA radiation, which seems to be more important in intermediate and high doses of this radiation.